Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Maud Barbery

1PUBLICATIONS

14CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 19, 2024

Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.

Allison Voisin, Catherine Terret, Camille Schiffler

Pageof 1

Frequent Collaborators

1 joint publications

Allison Voisin

1 joint publications

Catherine Terret

1 joint publications

Camille Schiffler

1 joint publications

Anne-Sophie Bidaux

1 joint publications

Hélène Vanacker

1 joint publications

Marlène Perrin-Niquet

1 joint publications

Armelle Vinceneux

1 joint publications

Lauriane Eberst

1 joint publications

Pierre Stéphan

1 joint publications

Gwenaële Garin

Frequent Collaborators

1 joint publications

Allison Voisin

1 joint publications

Catherine Terret

1 joint publications

Camille Schiffler

1 joint publications

Anne-Sophie Bidaux

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos